BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 5, 2017
View Archived Issues
Stanford University describes novel adrenergic receptor modulators
Read More
Saniona selects preclinical candidate for neuropathic pain and chronic itching
Read More
Roche's idasanutlin receives U.S. orphan designation for polycythemia vera
Read More
FDA names setmelanotide an orphan drug for treating leptin receptor deficiency
Read More
Ra Pharmaceuticals reports interim results from phase II study of RA-101495 in PNH
Read More
Topline phase IIa results reported from IW-1973 studies
Read More
FDA grants orphan drug status to Seres' microbiome therapeutic candidate
Read More
CKD273 biomarker panel predicts mortality in patients with diabetic nephropathy
Read More
Zebrafish model illuminates role of TTN gene variants in dilated cardiomyopathy
Read More
BL-8040 plus high-dose Ara-C improves overall survival in phase IIa study in r/r AML
Read More
FDA gives orphan drug designation to SHP-647 for pediatric ulcerative colitis
Read More
Lilly initiates phase I study of LY-3381916 alone and in combination with LY-3300054 in solid tumors
Read More
Pembrolizumab shows promise for drug-resistant gestational trophoblastic neoplasia
Read More
Burosumab shows positive results in phase III study in X-linked hypophosphatemia
Read More
ViiV Healthcare UK patents novel HIV integrase inhibitors
Read More
La Jolla Pharmaceutical initiates pivotal study of LJPC-401 in patients with beta thalassemia
Read More
Mustang Bio signs agreements with Harvard and Beth Israel Deaconess in cancer immunotherapy
Read More
Mirati Therapeutics and Array BioPharma describe new mutant KRAS inhibitors
Read More
Montreal Neurological Institute and Takeda Canada enter ALS research agreement
Read More
Evotec and Ncardia in licensing agreement for stem cell derived cellular disease modeling IP
Read More
Roche identifies novel compounds for hepatitis B virus infection
Read More
Probiodrug and Crossbeta extend strategic partnership in Alzheimer's biomarkers
Read More
Glenmark Pharmaceuticals identifies new nuclear receptor ROR-gamma antagonists
Read More
Tioga reports reduced nighttime itching in asimadoline study in atopic dermatitis
Read More
Foresee completes phase I studies of MMP-12 inhibitor FP-025
Read More
SymBio announces termination of license agreement with The Medicines Company
Read More
FDA issues new guidance on 3D printing
Read More
